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Abstract
Background: This epidemiological study was carried out in Sfax (south of Tunisia) and focused on genital
Chlamydia trachomatis (C. trachomatis) genovar distribution.
Methods: One hundred and thirty seven genital samples from 4067 patients (4.2%) attending the Habib Bourguiba
University hospital of Sfax over 12 years (from 2000 to 2011) were found to be C. trachomatis PCR positive by the
Cobas Amplicor system. These samples were genotyped by an in house reverse hybridization method.
Results: One hundred and eight (78.8%) samples contained only one genovar and 29 (21.2%) samples contained
two or three genovars. Genovar E was the most prevalent (70.8%) single genovar and it was detected in 90.6% of
all the cases. Genovars J, C and L1-L3 were not detected in our samples whereas ocular genovars A and B were in
5 cases. All the five cases were mixed infections. Men had more mixed infections than women (p=0.02) and were
more frequently infected by genovars F and K (p<0.05). No associations between current infection, infertility and
the genovar distribution were observed. Patients coinfected with Neisseria gonorrhoeae were also significantly more
frequently infected with mixed genovars (p=0.04).
Conclusions: In conclusion, we have reported a high prevalence of genovar E and of mixed infections in our study
population. Such data could have implications for the control and vaccine development of C. trachomatis in Tunisia.
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Background
Chlamydia trachomatis (C. trachomatis) infections are
the most common sexually transmitted bacterial infec-
tions in the world. The World Health Organization esti-
mated that 92 million new cases of Chlamydia
infections occurred globally in 2001 [1]. Genital infec-
tion with C. trachomatis is associated with a wide
spectrum of diseases if the infection was not treated. In
men, urogenital C. trachomatis infection causes urethritis
that may lead to complications such as epididymitis
in rare cases. In women, clinical manifestations show
cervicitis that can ascend in the upper genital tract and
cause pelvic inflammatory disease and infertility. The dis-
eases caused by C. trachomatis also include trachoma,
the world’s leading cause of preventable blindness [2] as
well as lymphogranuloma venereum (LGV), a severe sys-
temic infection [3].
C. trachomatis strains are conventionally divided into
19 genovars based on the heterogeneity of the ompA
gene sequence. The different genovars of C. trachomatis
are associated with the various clinical manifestations
caused by this bacterium. Genovars A to C are predom-
inantly associated with trachoma and were rarely
detected in urogenital diseases. Genovars D to K are
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associated with urogenital diseases, and genovars L1 to
L3 are associated with the LGV. C. trachomatis genovars
are also classified into 3 distinct groups on the basis
of their amino acid sequence homology: the B group
(B, Ba, D, Da, E, L1, L2a and L2b), the C group (A,
C, H, I, Ia, J, Ja, K and L3) and the intermediate group
(F and G) [4].
In the previous studies performed in Tunisia, C. tra-
chomatis was reported in 15% among men with ureth-
ritis (data not published), in 59% among patients with
arthritis [5], in 43.3% among infertile men with leukocy-
tospermia [6] and in 73% of prostitutes [7]. Thus, C. tra-
chomatis infection seems to be prevalent in our country,
but no information about C. trachomatis genovar distri-
bution in our population has been described so far.
Thus, we undertook this study to genotype C. tracho-
matis strains circulating in Tunisia using our in house
reverse hybridization method. We also aimed to assess
the relationship between gender, age, clinical and micro-
biological factors and C. trachomatis genovars. Such data
might give insights into the C. trachomatis strains circu-
lating in Tunisia and help develop strategies of sexually
transmitted infections control.
Methods
Clinical C. trachomatis samples
One hundred and seventy two urethral and/or en-
docervical swabs positive for C. trachomatis using
Cobas Amplicor (Roche molecular system, Mannheim
Germany), were collected from Tunisian patients at the
Habib Bourguiba University hospital in Sfax between
February 2000 and June 2011. Specimens were collected
using cytobrush, and the contents were transferred im-
mediately into a tube containing 1ml 2-SP transport
medium. Specimens were kept at −80°C until testing.
These specimens were also tested for Neisseria gonor-
rhoeae (N. gonorrhoeae) nucleic acids with the Amplicor
CT/NG polymerase chain reaction (PCR). DNA extrac-
tion from 200μl 2-SP transport medium and PCR proce-
dures were performed according to the manufacturer’s
instructions.
All subjects provided verbal informed consent, and the
study protocol was approved by our ethics committee
(Association d’Enregistrement et de Lutte Contre le
Cancer du Sud Tunisien).
Extraction of genomic DNA
Genomic DNA from clinical swabs was extracted from
200 μl of urethral and endocervical swabs using the
QIAmp DNA Mini kit (QIAGEN GmbH, Hilden,
Germany) according to the manufacturer’s instructions.
The DNA was then eluted in 50 μl of the elution buffer
and stored at −20°C. The extracted DNA was tested for
human ß-globin gene to check for PCR inhibitors in the
samples. Primers ß-GPCO (50-ACACAACTGTGTT
CACTAGC- 30), and ß-GPCPO (50-GAAACCCAA
GAGTCTTCTCT- 30), were used to amplify a 209 bp
fragment of the human ß-globin gene.
PCR amplification of the VS1-VS2 fragment
Urethral and endocervical DNA positive by Cobas
Amplicor C. trachomatis test were selected for the ompA
amplification and genotyping. A semi nested PCR was
used for the amplification using the NLO (Biotin-
ATGAAAAAACTCTTGAAATCG) [8] and C214 (Bio-
tin-TCTTCGAYTTTAGGTTTAGATTGA) [9] primers
for the first PCR and the NLO and CT4 (Biotin-GATT
GAGCGTATTGGAAAGAAGC) [10] primers for the
semi nested PCR. The reaction mixture consisted of 3μl
of extracted DNA, 0.5μM of each primer, 0.2 mM dNTP;
1U of the flexi Taq DNA polymerase (Promega, Madison
WI, USA). PCRs were performed using the GeneAmp
PCR System 9600 thermocycler under the following con-
ditions: 2 min of denaturation at 95°C, followed by 35
cycles of amplification at 95°C for 45 sec, 45°C for 45
sec, and 72°C for 45 sec. The ompA PCR products were
visualized after electrophoresis in 1% agarose gels by
ethidium bromide staining.
The reverse hybridization method
An in house reverse hybridization method for C. tracho-
matis genotyping was first developed in our laboratory
and was validated using 14 C. trachomatis reference
strains [11]. Then this method was used for the specific
detection of C. trachomatis genotypes. Briefly, the nylon
membrane was spotted with probes hybridizing specific-
ally to genovars A to L3 at specific positions. Reverse
hybridization probes were then attached to the mem-
brane by baking at 120°C for 30 min. Membranes were
prehybridized for 30 min at 37°C and then hybridization
took place over the night at 37°C with shaking. The bio-
tinylated duplex DNA-probe was revealed after incuba-
tion with the alkaline phosphatase enzyme for one hour
at 37°C and then with its substrate: the Western Blue
stabilized substrate (Promega, Madison WI, USA) for
30 min at room temperature and in the dark. Washing
was performed between each of the incubation steps.
Statistical analysis
Data were analyzed using SPSS version 13.0. Differences
were statistically compared by the Chi-square test or the
Fisher’s exact test when sample sizes were small. p < 0.05
was considered as significant.
Results
During twelve years, urethral and endocervical swabs
from 4067 Tunisian patients were collected in the Habib
Bourguiba University hospital in Sfax between February
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2000 and June 2011 and were subjected to the Cobas
Amplicor CT/NG PCR testing. One hundred and sev-
enty two samples (4.2%) were found to be PCR positive
and only 138 were available for C. trachomatis genotyp-
ing. Of these 138 samples, 84 (60.9%) were collected
from men and 54 (39.1%) from women. Data on age
were obtained from 115 individuals. The median age
was 30 years and the 95% confidence interval was
[28.85-31.45]. Thirty two individuals (23.9%) were under
25 years. Thirty seven individuals (27%) were consulted
for infertility (5 men and 32 women), 96 (70%) for the
current infection (76 men and 20 women) and one man
consulted for both infertility and the current infection
(0.7%). Data were not available for the remaining 3
patients (2.2%). Mixed infections with N. gonorrhoeae
were detected in 18 cases (13.1%) (Table 1).
All the 138 samples C. trachomatis Cobas PCR posi-
tive were successfully screened by the β-globin PCR test
and no inhibition was detected. One hundred and thirty
seven samples were then amplified by our semi nested
PCR, generating a sensitivity of 99%. These amplicons
were used for the detection of C. trachomatis genotypes
by the reverse hybridization method. Genovar distribu-
tion results of the 137 samples are shown in Table 1. A
heterogeneous distribution of the 137 C. trachomatis
genovars was observed. All genovars belonging to the
D–K urogenital group were detected except the genovar
J. One hundred and eight samples (78.8%) were infected
with a single genovar. The remaining 29 samples (21.2%)
showed mixed infections. Genovar E was the most
prevalent (70.8%) single infection. In single and mixed
infections together, genovar E was detected in 90.6% of
cases (124/137). The most prevalent mixed infection was
observed to be genovars E and F, and E and H. Genovar
B was detected in mixed infection with genovar E in two
cases and with genovars D and H in one case. Genovar
A was detected in mixed infections with genovar E in
one case and with genovars E and F in one case. Geno-
var C and LGV genovars were not detected in our uro-
genital samples. The genovar distribution was also
investigated according to the year of collection of sam-
ples (Additional file 1: Table S1). Generally, all single
and mixed genotypes were distributed all over the 12
years.
The relationships between gender, age, current C. tra-
chomatis infection, infertility, N. gonorrhoeae infection
data and C. trachomatis genotypes or group results were
examined (Table 2). No statistical differences were
observed for the distribution of C. trachomatis geno-
types between men and women (p<0.05). However, sig-
nificantly more men had mixed infections (p=0.02) than
women. Genovars F and K were observed more fre-
quently in men than in women (p<0.05) too. In fact,
10.7% and 3.7% of men and women, respectively, were
infected with genovar F and 8.3% and 1.8% respectively
with genovar K. No association was observed between
age, current infection, infertility and the genovar distri-
bution. Patients infected with N. gonorrhoeae were also
significantly more frequently infected by mixed infection
(p=0.04), and by genovars other than E alone (p=0.03)
(Table 2).
Discussion
Many studies have reported the epidemiology of C. tra-
chomatis infection throughout the world. The prevalence
of C. trachomatis infections varies from 2% to 5.6% in
selected and unselected populations [12]. In line with
previous studies, the prevalence of C. trachomatis infec-
tion in our city of Sfax was found to be 4.2%. To our
knowledge, C. trachomatis genovar distribution has not
been reported before in our country. C. trachomatis
genotyping was investigated in all urogenital samples
collected in Sfax (Tunisia) found to be Cobas amplicor
PCR positive since 2000. Ninety nine percent (137/138)
of our samples were successfully amplified using our
semi nested PCR. This sensitivity is high when compared
with those reported in other studies ranging from 44 to
99% [10,13-15].
The reverse hybridization used in our study is simple
and fast. It requires low technology to be performed. It
is powerful in the diagnosis of mixed infection and did
not show any cross reactivity between reference strains.
In our study, genotype E was the most prevalent being
detected in 70.2% of single infections. All the other gen-
otypes were detected at percentages ranging from 0.7 to
2.2%. When considering single and mixed infections,
genovar E was detected in 92.6% of the cases followed
by genovar F that was detected in 10.3% of the cases.
The detection of genovar E was remarkably high in our
study but was in line with that of Gita et al., [13]
performed in New Delhi (India) reporting the de-
tection of only genovar E in 22 specimens positive for
C. trachomatis by PCR-RFLP. Their high percentage was
explained by the small number of specimen processed
which was not so in our case. According to the litera-
ture, genovars D, E, F and G were reported to be the
most prevalent genovars worldwide [8,9,16-21]. Differ-
ences in the relative proportions of these genovars in dif-
ferent geographical areas were reported. For example, in
Cambodia, genovar D (22.2%) was the most prevalent
followed by genovar F (18.5%) [22]. In Australia, the
most common genovar was E (41%) followed by genovar
F (26%) [23]. In Sweden, the most common genovar was
E (47%) followed by genovar F (17%) [15]. Differences in
genotype prevalence were found in different study popu-
lations. In Thailand, genovar F was the most prevalent
genotype (60%) among non sex workers, but decreased
to 29% among sex workers [24]. The high detection rate
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p value Current infection *
N = 96 (%)
p value Infertility *
N = 37 (%)
p value NG coinfection
N = 18 (%)
p value
Gender Men
N = 84 (%)
Women













Single 108 (78.8) 61 (72.6) 47 (88.7) 0.03 54 (40.6 ) 18 (13.5) 0.14 5 (3.6) 28 (21) 1.00 9 (8.0) 2 (1.5) 0.49
D 2 (1.5) 0 (0) 2 (3.8) 0.14 0 (0) 2 (1.5) 0.04 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
E 97 (70.8) 55 (65.5) 42 (79.2) 0.12 49 (36.8) 14 (10.5) 0.79 4 (3) 27 (20.3) 1.00 7 (6.5) 2 (1.5) 0.47
F 4 (2.9) 4 (4.8) 0 (0) 0.16 3 (2.2) 0 (0) 1.00 1 (0.7) 0 (0) 0.14 1 (0.7) 0 1.00
G 3 (2.2) 0 (0) 3 (5.7) 0.06 0 (0) 2 (1.5) 0.04 0 (0) 1 (0.7) 1.00 0 (0) 0 (0) Nd
H 1 (0.7) 1 (1.2) 0 (0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
K 1 (0.7) 1 (1.2) 0 (0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 1 (0.7) 0 (0) 1.00
Multiple 29 (21.2) 23 (27.4) 6 (11.3) 0.03 22 (16.1) 2 (1.5) 0.14 0 (0) 4 (3) 1.00 7 (5.1) 0 (0) 0.49
A + E 1 (0.7) 1 (1.2) 0 ( 0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
B + E 2 (1.5) 0 (0) 2 (3.8) 0.15 0 (0) 1 (0.7) 0.21 0 (0) 1 (0.7) 1.00 0 (0) 0 (0) Nd
D + F 1 (0.7) 1 (1.2) 0 (0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
E + F 5 (3.6) 4 (4.8) 1 (1.9) 0.65 4 (3) 0 (0) 0.58 0 (0) 1 (0.7) 1.00 0 (0) 0 (0) Nd
E + G 4 (2.9) 4 (4.8) 0 (0) 0.16 4 (3) 0 (0) 0.58 0 (0) 0 (0) Nd 2 (1.5) 0 (0) 1.00
E + H 5 (3.6) 4 (4.8) 1 (1.9) 0.65 4 (3) 0 (0) 0.58 0 (0) 1 (0.7) 1.00 2 (1.5) 0 (0) 1.00
E + K 3 (2.2) 3 (3.6) 0 (0) 0.28 3 (2.2) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
E + I 1 (0.7) 1 (1.2) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd 1 (0.7) 0 (0) 1.00
A + E + F 1 (0.7) 0 (0) 1 (1.9) 0.39 0 (0) 0 (0) Nd 0 (0) 1 (0.7) 1.00 0 (0) 0 (0) Nd
B + D + H 1 (0.7) 1 (1.2) 0 ( 0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 1 (0.7) 0 (0) 1.00
E + F + H 1 (0.7) 1 (1.2) 0 ( 0) 1.00 1 (0.7) 0 (0) 1.00 0 (0) 0 (0) Nd 0 (0) 0 (0) Nd
E + H + K 4 (2.9) 3 (3.6) 1 (1.9) 1.00 3 (2.2) 1 (0.7) 1.00 0 (0) 0 (0) Nd 1 (0.7) 0 (0) 1.00
Statistically significance is marked in bold.





















of genovars D, E, F, and G could be related to a longer
persistence time of their infections than the other geno-
vars in the genital tract [25].
The high prevalence of genovar E in our study could
be explained by a specific immune status of Tunisian
patients and by distinctive characteristics of some geno-
type E strains in our country. Such strains could not be
distinguished by our reverse hybridization method.
Thus, the application of new typing schemes based
on more discriminative method such as multilocus
sequence typing or multiple loci variable number of
tandem repeats analysis might provide a better under-
standing of our high prevalence of C. trachomatis
genovar E. An interesting issue would be to further
examine whether all or most of the genovar E in our
patients were of the same strain or not. Furthermore, an
assessment of in vitro studies of infectivity and cytotox-
icity of our local strains in urogenital cell lines may also
help to explain the high prevalence of genovar E in our
population. Jones et al., [26] suggested that genovar E
can outcompete other genovars for nutrients and growth
factors leading to a rapid expansion of genovar E when
compared to the other genovars.
Mixed infections were detected in our study in 21.1%
of the cases. This percentage seems to be high as most
of mixed infections in the literature occur at a percent-
age not exceeding 15% [19,27-30]. Mixed infections may
result from two separate episodes of infection and the
lack of cross protection between genotypes [14]. In our
study, single genovars were rarely detected except for
genovar E. Genovars H and K were detected once in sin-
gle infections but were detected at high frequencies in
mixed infections (11 and 7 times, respectively). These
genovars are probably relatively low grade pathogens
which could only persist in the presence of other geno-
vars [31].
Trachoma genovars A and B were also detected in 5
patients (3.6%). All of them were observed in mixed
infections. This could not be due to cross reactivity since
our technique was well studied with a mixture of refer-
ence strains. Also, these genovars were involved in uro-
genital infections [32-37].
The genovar detection in our study was similar among
men and women in line with previous studies suggesting
that specific serotypes do not preferentially infect one
gender [23,38]. However, the occurrence of mixed infec-
tions is significantly higher among men than women.
Furthermore, a statistically significant difference was
found for the occurrence of genovars F and K which
were observed more frequently in men than in women.
Men are probably sexually active with more than one
partner leading to the occurrence of mixed infections
and infection with another genovar than E. No statisti-
cally significant difference in distribution of genotypes
and age was found such a result is in a total agreement
with other studies [39].
In our study, no association was found between C. tra-
chomatis genotype E and the patient’s infection status
(current symptomatic infection and infertility). Accord-
ing to the literature, genovar E was reported at high fre-
quencies in symptomatic adults [40] as well as in
asymptomatic adults [16,18,19]. C. trachomatis genovar
E was also found in our study to be the most prevalent
genovar. In infertile patients from Mexico, C. trachoma-
tis genovar F was the most prevalent genovar (54%) fol-
lowed by genovars E, G, K and LGV (9%) [41].














Gender Men (84) 61 (56.5) 23 (79.3) 55 (56.7) 21 (77.8) 55 (56.7) 29 (72.5)
Women (53) 47 (43.5) 6 (20.7) 42 (43.3) 6 (22.2) 42 (43.3) 11 (27.5)
p 0.02 0.04 NS
Age * <= 25 (32) 22 (24.4) 10 (40) 20 (24.4) 9 (39.1) 20 (24.4) 12 (36.4)
>25 (83) 68 (75.6) 15 (60) 62 (75.6) 14 (60.9) 62 (75.6) 21 (63.6)
p NS NS NS
Infertility ‡ Presence (37) 33 (24.8) 4 (30) 31 (23.3) 4 (30) 31 (23.3) 6 (4.5)
p NS NS NS
Current infection ‡ Presence (96) 72 (54.1) 24 (18) 63 (47.3) 17 (12.8) 63 (47.3) 33 (24.8)
p NS NS NS
NG coinfection Presence (18) 11 (10.2) 7 (24.1) 9 (9.3) 6 (22.2) 9 (9.3) 9 (22.5)
p 0.04 NS 0.03
Statistically significance is marked in bold.
* The age data were available for only 115 patients.
‡The status of infection was not available only for 3 patients. One patient, presenting both current infection and infertility, was discarded from the analysis.
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Patients with N. gonorrhoeae infection were signifi-
cantly more frequently infected by mixed genovars and
by genovars other than the single genovar E (Table 2).
According to the literature, little is known about N.
gonorrhoeae coinfection and its association with C. tra-
chomatis genovars. Papadogeorgakis et al., [36] reported
a significantly higher proportion of N. gonorrhoeae coin-
fections among patients with urethritis with genovariant
Ja. No other associations were reported except for the
significant association of N. gonorrhoeae coinfection with
genovar D [42].
Yet, we could mention a few limitations of our study.
First, the smaller sample size of infected patients could
affect the relationship between C. trachomatis genotypes
and clinical manifestations. Second, supplementary in-
formation about behavioral characteristics would be use-
ful to explain the difference in genotype distribution
among men and women. In addition, the reverse
hybridization method used in this study could not detect
new genovars and recombinant clinical strains. These
could lead to cross hybridizations [11]. The presence of
trachoma genotypes and the high frequency of mixed
infections have to be confirmed by cloning and complete
ompA gene sequencing.
Conclusion
In conclusion, the present study is the first description
of C. trachomatis genovar distribution in Tunisia. C. tra-
chomatis genotype E infection rate was found to be con-
siderably much higher than other reports in the world.
We have also detected a high frequency of mixed infec-
tions. This genotype distribution is unique and further
studies focused on specific groups are needed to assess
whether this figure is specific to Tunisia only. The data
obtained in this study could have implications for the
control and vaccine development of C. trachomatis in
Tunisia.
Additional file
Additional file 1: Table S1. The prevalence of C. trachomatis in
Tunisian patients.
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